Design Therapeutics, Inc. — 10-Q Filings
15 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Design Therapeutics, Inc. (DSGN), sorted by most recent first. Each row links to the full filing on EdgarLookup. Design Therapeutics, Inc. has filed 15 10-Q documents with the SEC since 2020. To view all SEC filings by Design Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
3/A
4
4/A
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DEFR14A
DRS
EFFECT
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001193125-25-266970 | Nov 5, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-105062 | Aug 7, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-065643 | May 7, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0000950170-24-123349 | Nov 7, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-090337 | Aug 5, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-055788 | May 8, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0000950170-23-062958 | Nov 13, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-042411 | Aug 14, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-019714 | May 9, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0000950170-22-021885 | Nov 3, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-015533 | Aug 8, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-008500 | May 9, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0000950170-21-003753 | Nov 9, 2021 | Sep 30, 2021 |
| 10-Q | 10-Q | 0001564590-21-042734 | Aug 9, 2021 | Jun 30, 2021 |
| 10-Q | 10-Q | 0001564590-21-026062 | May 10, 2021 | Mar 31, 2021 |